An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date.

Drug Des Devel Ther · 2021 · PMC8434836 · PMID 34522085

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Also, the responses showed a trend towards improvement with continued lenalidomide treatment, as 34% of patients achieved their best responses only in the maintenance phase.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.